FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559979608> ?p ?o ?g. }

• W2559979608 abstract "Abstract Abstract 1002 Fetal hemoglobin (HbF) levels significantly modulate the severity of the 2 major β-hemoglobin disorders - sickle cell anemia (SCA) and β-thalassemia. Three major quantitative trait loci (QTLs; Xmn1-HBG2, the HBS1L-MYB [HMIP] intergenic region on chromosome 6q23, and BCL11A on chromosome 2p16) account for 20–50% of the common variation in HbF levels in SCA and β - thalassemia patients, and in healthy adults (Thein et al., Hum Mol Genet (2009) 18:R216). Lettre et al. (PNAS (2008) 105:11869) confirmed the influence of SNPs at the BCL11A and HBB loci in an African American cohort and a Brazilian cohort of SCA patients; as well as a significant influence of the HMIP region SNPs (rs7776054, rs9389268 and rs4895441) on HbF expression in the Brazilian SCA cohort. A strong association between HMIP polymorphisms that have a high frequency in the European population and modulation of F cell numbers has been reported (Creary et al., PLoS One (2009) 4:e4218). Given the unusually high admixture of the Brazilian population, the current study aimed to look at the influence of such HMIP markers on HbF production in SCA patients from this population (two regions, in the Northeast and Southeast of Brazil). We studied the influence and frequencies of the HMIP allele marker rs9376090 (that specifically tracks European chromosomes), as well as the rs9399137 marker (that has a much higher frequency in European descendents than in African descendents), as well as two HMIP markers (rs9389269 and rs9402686) that are also common in African descendents. Patients (220 HbSS, aged 12–68 years) were recruited at the Hematology Center, UNICAMP and at Fundação Hemope. The study was approved by the local Ethics Committees and informed consent was provided by all participants. Patients presenting the XmnI Gγ polymorphism (N = 2) were identified and excluded from further analysis, as this polymorphism has a known influence on HbF. The HMIP markers were genotyped by Taqman assays. Percentage HbF levels were determined by HPLC, using the Variant™ Bio-Rad kit, and were log transformed to normalize distribution for regression analyses. For those patients on hydroxyurea (HU) therapy, pre-HU HbF levels were used for analyses. Tests for associations between SNPs and HbF levels were conducted using linear regression models (SPSS v.15), including age and sex as covariates. High minor allele frequencies (MAF) for all four HMIP markers were observed in the population of patients studied (MAF; 0.09, 0.10, 0.12 and 0.12 for the rs9376090, rs9399137, rs9389269 and rs9402686 markers, respectively). For all four SNPs studied, higher levels of HbF were observed for the SCA individuals that were homozygotes for the minor allele, with strikingly higher levels of HbF presented by those individuals that were homozygotes for the rs9376090 and rs9399137 polymorphisms (see Table). The clinical courses of these patients were consistent with the higher levels of HbF observed (data not shown). Significantly higher HbF was also found in heterozygotes for the HMIP SNPs, compared to the major allele homozygotes. The variance in HbF levels due to rs9376090 was 7.1% (β= 0.270; p = 6.36 10−5), due to rs9399137 was 7.1% (β= 0.270; p = 9.59 10−5), due to rs9389269 was 8.3% (β= 0.287; p = 2.31 x10−5) and to rs9402686 was 8.3% (β=0.291; p = 2.18 x10−5). Our results confirm the HBS1L-MYB intergenic region as a key determinant of HbF levels in Brazilian SCA patients. The admixture of the Brazilian population has apparently led to a much higher incidence of European haplotypes at chromosome 6 in this population studied, when compared to the British and Tanzanian SCA populations. Importantly, the presence of these SNPs at the HMIP appears to have a very significant effect on HbF levels in the Brazilian SCA population, with probable clinical benefits. Table. HbF Levels in SCA Individuals, according to HMIP genotypes SNP (HBS1L-MYB locus) % HbF (Median ± S.D.) TT TC CC rs9376090 6.35 ± 4.24 8.45 ± 3.63 17.25 ± 1.63 N = 182 N = 32 N=2 p<0.01 p<0.05 rs9399137 6.47 ± 4.38 8.68 ± 3.63 17.25 ± 1.63 N = 167 N=37 N = 2 p<0.05 p< 0.05 rs9389269 6.40 ±4.29 8.59 ± 3.70 12.68 ± 2.45 N = 162 N = 42 N = 5 p< 0.01 p< 0.05 rs9402686 GG AG AA 6.26 ± 4.28 8.36 ± 4.67 12.68 ± 2.45 N =166 N = 41 N = 5 p<0.01 p<0.05 Significant differences for heterozygotes and homozygotes for the minor allele, compared to the homozygote major allele group are indicated by P values. Kruskal-Wallis test, Dunn's multiple comparison post test. Disclosures: No relevant conflicts of interest to declare." @default.
• W2559979608 created "2016-12-16" @default.
• W2559979608 creator A5050058477 @default.
• W2559979608 creator A5052681436 @default.
• W2559979608 creator A5061822217 @default.
• W2559979608 creator A5067214624 @default.
• W2559979608 creator A5067515209 @default.
• W2559979608 creator A5067713063 @default.
• W2559979608 creator A5070904578 @default.
• W2559979608 creator A5076081716 @default.
• W2559979608 creator A5081559712 @default.
• W2559979608 date "2012-11-16" @default.
• W2559979608 modified "2023-09-30" @default.
• W2559979608 title "European Chromosome 6 Haplotypes Significantly Augment Fetal Hemoglobin Levels in Brazilian Sickle Cell Anemia Patients: Influence of Four HBS1L-MYB Intergenic Region SNPs" @default.
• W2559979608 doi "https://doi.org/10.1182/blood.v120.21.1002.1002" @default.
• W2559979608 hasPublicationYear "2012" @default.
• W2559979608 type Work @default.
• W2559979608 sameAs 2559979608 @default.
• W2559979608 citedByCount "0" @default.
• W2559979608 crossrefType "journal-article" @default.
• W2559979608 hasAuthorship W2559979608A5050058477 @default.
• W2559979608 hasAuthorship W2559979608A5052681436 @default.
• W2559979608 hasAuthorship W2559979608A5061822217 @default.
• W2559979608 hasAuthorship W2559979608A5067214624 @default.
• W2559979608 hasAuthorship W2559979608A5067515209 @default.
• W2559979608 hasAuthorship W2559979608A5067713063 @default.
• W2559979608 hasAuthorship W2559979608A5070904578 @default.
• W2559979608 hasAuthorship W2559979608A5076081716 @default.
• W2559979608 hasAuthorship W2559979608A5081559712 @default.
• W2559979608 hasConcept C104317684 @default.
• W2559979608 hasConcept C126322002 @default.
• W2559979608 hasConcept C135763542 @default.
• W2559979608 hasConcept C153209595 @default.
• W2559979608 hasConcept C172680121 @default.
• W2559979608 hasConcept C180754005 @default.
• W2559979608 hasConcept C197754878 @default.
• W2559979608 hasConcept C203014093 @default.
• W2559979608 hasConcept C2776175824 @default.
• W2559979608 hasConcept C2776317666 @default.
• W2559979608 hasConcept C2777799968 @default.
• W2559979608 hasConcept C2779234561 @default.
• W2559979608 hasConcept C2779668550 @default.
• W2559979608 hasConcept C2908647359 @default.
• W2559979608 hasConcept C37463918 @default.
• W2559979608 hasConcept C54355233 @default.
• W2559979608 hasConcept C71924100 @default.
• W2559979608 hasConcept C72563966 @default.
• W2559979608 hasConcept C86803240 @default.
• W2559979608 hasConcept C99454951 @default.
• W2559979608 hasConceptScore W2559979608C104317684 @default.
• W2559979608 hasConceptScore W2559979608C126322002 @default.
• W2559979608 hasConceptScore W2559979608C135763542 @default.
• W2559979608 hasConceptScore W2559979608C153209595 @default.
• W2559979608 hasConceptScore W2559979608C172680121 @default.
• W2559979608 hasConceptScore W2559979608C180754005 @default.
• W2559979608 hasConceptScore W2559979608C197754878 @default.
• W2559979608 hasConceptScore W2559979608C203014093 @default.
• W2559979608 hasConceptScore W2559979608C2776175824 @default.
• W2559979608 hasConceptScore W2559979608C2776317666 @default.
• W2559979608 hasConceptScore W2559979608C2777799968 @default.
• W2559979608 hasConceptScore W2559979608C2779234561 @default.
• W2559979608 hasConceptScore W2559979608C2779668550 @default.
• W2559979608 hasConceptScore W2559979608C2908647359 @default.
• W2559979608 hasConceptScore W2559979608C37463918 @default.
• W2559979608 hasConceptScore W2559979608C54355233 @default.
• W2559979608 hasConceptScore W2559979608C71924100 @default.
• W2559979608 hasConceptScore W2559979608C72563966 @default.
• W2559979608 hasConceptScore W2559979608C86803240 @default.
• W2559979608 hasConceptScore W2559979608C99454951 @default.
• W2559979608 hasLocation W25599796081 @default.
• W2559979608 hasOpenAccess W2559979608 @default.
• W2559979608 hasPrimaryLocation W25599796081 @default.
• W2559979608 hasRelatedWork W1553958387 @default.
• W2559979608 hasRelatedWork W1970937932 @default.
• W2559979608 hasRelatedWork W2064494098 @default.
• W2559979608 hasRelatedWork W2388810824 @default.
• W2559979608 hasRelatedWork W2412082239 @default.
• W2559979608 hasRelatedWork W2414400106 @default.
• W2559979608 hasRelatedWork W2547039227 @default.
• W2559979608 hasRelatedWork W2580378906 @default.
• W2559979608 hasRelatedWork W2618627340 @default.
• W2559979608 hasRelatedWork W2888206301 @default.
• W2559979608 hasRelatedWork W2907300651 @default.
• W2559979608 hasRelatedWork W2914160107 @default.
• W2559979608 hasRelatedWork W2997722393 @default.
• W2559979608 hasRelatedWork W3031308037 @default.
• W2559979608 hasRelatedWork W3032769839 @default.
• W2559979608 hasRelatedWork W3081663049 @default.
• W2559979608 hasRelatedWork W3097788921 @default.
• W2559979608 hasRelatedWork W3153861837 @default.
• W2559979608 hasRelatedWork W3199324677 @default.
• W2559979608 hasRelatedWork W572583209 @default.
• W2559979608 isParatext "false" @default.
• W2559979608 isRetracted "false" @default.
• W2559979608 magId "2559979608" @default.
• W2559979608 workType "article" @default.